Table 2

Effect of BMS-180448 with or without glyburide on postischemic cardiac function and coronary flow in isolated rat hearts

PredrugReperfusion 30 min
HR (bpm)
 Vehicle282  ± 7210  ± 52-a
 10 μM BMS (reper only)290  ± 12286  ± 92-b
 1 μM GLY (reper only)274  ± 9215  ± 252-a
 10 μM BMS + 1 μM GLY (reper only)275  ± 10218  ± 202-a
 10 μM BMS (pre/postisch)286  ± 7276  ± 92-b
 10 μM BMS + 1 μM GLY (pre/postisch)280  ± 6217  ± 232-a
LVDP (mm Hg)
 Vehicle130  ± 1018  ± 32-a
 10 μM BMS (reper only)129  ± 638  ± 3a,b
 1 μM GLY (reper only)134  ± 516  ± 52-a
 10 μM BMS + 1 μM GLY (reper only)130  ± 521  ± 42-a
 10 μM BMS (pre/postisch)137  ± 585  ± 6a,b
 10 μM BMS + 1 μM GLY (pre/postisch)135  ± 515  ± 32-a
Coronary flow (ml/min/g)
 Vehicle18.6  ± 1.012.8  ± 1.12-a
 10 μM BMS (reper only)18.1  ± 0.514.7  ± 1.12-a
 1 μM GLY (reper only)18.2  ± 0.68.3  ± 0.62-a
 10 μM BMS + 1 μM GLY (reper only)19.9  ± 1.214.1  ± 0.92-a
 10 μM BMS (pre/postisch)19.8  ± 2.718.2  ± 1.92-b
 10 μM BMS + 1 μM GLY (pre/postisch)19.3  ± 3.611.6  ± 1.02-a
  • All values are mean ± S.E.M.; BMS, BMS-180448; GLY, glyburide; reper only, treatment only during reperfusion; pre/postisch, treatment both before and after ischemia.

  • 2-a Significantly different from its respective predrug value (P < .05).

  • 2-b Significantly different from its respective vehicle group value (P < .05).